[HTML][HTML] Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP
X Huang, B Meng, J Iqbal, BB Ding… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
Journal of clinical oncology, 2013•ncbi.nlm.nih.gov
Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large
B-Cell Lymphoma Treated With R-CHOP - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search
PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC3871513 Other Formats PDF (661K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
B-Cell Lymphoma Treated With R-CHOP - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search
PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC3871513 Other Formats PDF (661K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Abstract
Purpose
We previously reported that constitutive STAT3 activation is a prominent feature of the activated B-cell subtype of diffuse large B-cell lymphomas (ABC-DLBCL). In this study, we investigated whether STAT3 activation can risk stratify patients with DLBCL.
ncbi.nlm.nih.gov